New research indicates that an individual's genetic makeup, specifically variations in two genes linked to appetite and digestion, could be a determining factor in the effectiveness of popular weight loss medications such as Wegovy, Mounjaro, and Ozempic.

The article explores whether a lack of appetite, driven by the increasing use of GLP1 weight-loss drugs, poses a significant threat to the food sector. Currently, 6% of Spaniards use these drugs, with projections indicating a rise to 15-20% in a few years.

New research indicates that individuals with specific variations in genes linked to appetite and digestion may experience greater weight loss when using drugs designed to treat obesity, with DNA helping to determine treatment success.

The CEO of Novo Nordisk stated that the surge in demand for weight-loss medications is just beginning, indicating significant future growth in the market.

A discussion on self-love and body image in the era of weight-loss drugs like Ozempic highlights how social media influences young people, with a mother from Bratislava noting her 12-year-old daughter's appearance concerns after joining Instagram.

Generic versions of popular weight-loss medications like Ozempic and Wegovy are anticipated to become available in Canadian pharmacies this summer, offering more affordable alternatives to patients currently paying $300-$400 monthly for brand-name drugs. This development could significantly impact access and cost for weight management treatments.

Increased access to weight-loss medications has sparked discussions regarding potential concerns and the need for regulatory prudence, while also raising expectations for reduced healthcare spending, particularly in countries like India.

Indian pharmaceutical billionaires are heavily investing in generic weight-loss drugs, a trend that has attracted significant regulatory scrutiny from authorities.

The Health Products Regulatory Authority (HPRA) reported a 'substantial' increase in fake or illegal weight-loss drugs seized last year, with the number of units surging from 1,582 to 48,752.

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Peloton is launching a new strategy for its comeback, targeting users of GLP-1 weight-loss drugs and expanding its treadmill offerings.

The HSE was recently advised that the ‘price of the medicine is too high compared with other ways to manage this condition’.

Despite a significant share price drop, Zealand Pharma's CEO remains optimistic, while Novo Nordisk anticipates competition from cheaper generic versions of its weight-loss drugs entering major markets this year.

An obesity meet in Chennai, India, brought together doctors, nutritionists, and coaches to discuss approaches beyond GLP-1 weight-loss drugs like Ozempic. The event focused on promoting strength training and science-backed diets to combat rising obesity rates and dismantle the stigma around 'celebrity jabs'.

The market for weight-loss drugs is booming - but the pioneer in the field is shedding profits and share value, writes Adam Maguire

Berberine has gained popularity as a 'plant equivalent' to weight-loss drugs like Ozempic. Researchers from Wrocław Medical University are reviewing its efficacy to determine if it's a scientific breakthrough or a myth.

Country star Luke Combs opens up in a Popcast interview about his struggles with body image and explains why he chooses not to use weight-loss drugs, stating he prefers not to take 'the short way'.

The British government is introducing bonuses for general practitioners in England, averaging £3,000, to encourage them to prescribe weight-loss medications as part of an effort to combat rising obesity rates.

In 2025, 16,692 Icelanders used weight-loss drugs like Wegovy and Saxenda, spending nearly 3.5 billion Icelandic krónur annually, averaging over 200,000 krónur per person.

A son's credit rating was severely damaged after he combined finances with his girlfriend, who reportedly spent over $1,000 monthly on weight-loss drugs.

Jelly Roll's wife has revealed disturbing side effects she experienced from using weight-loss drugs, bringing attention to the potential adverse reactions of such medications.

Eli Lilly is losing market share in India's GLP-1 market due to the influx of cheap semaglutide generics, while Novo Nordisk maintains its position through price cuts for Ozempic and Wegovy.

An overview of the rapidly growing GLP-1 market details the costs of popular weight-loss medications like Wegovy, Zepbound, and Foundayo, and offers advice on choosing the best option.

An operation has been launched against groups involved in the illicit chain of weight-loss products, targeting fraudulent importation, distribution, and irregular commercialization of injectable substances.

The chief of Novo Nordisk estimates that the pharmaceutical industry is currently reaching only a fraction of potential customers for weight-loss drugs, indicating a massive untapped market.

Insurance companies are increasingly cutting off coverage for popular weight-loss medications like Zepbound, leaving patients who have seen significant results without access to their prescriptions.

Amidst the boom in weight-loss medications, a dangerous blind spot has emerged regarding compounding pharmacies, which are reportedly producing unapproved versions of these drugs.

Chinese manufacturers of weight-loss drugs are preparing to compete with global pharmaceutical giants as Novo Nordisk's patent for its popular weight-loss medication expires.

Hims & Hers Health has announced it is now selling Novo Nordisk's popular weight-loss medications, Wegovy and Ozempic, expanding access to these treatments.

India's patent for semaglutide is set to expire on March 20, leading to expectations that approximately 50 branded generic weight-loss drugs will enter the market.

With the introduction of multiple generic variants of GLP-1-weight-loss drugs in the Indian market, concerns have emerged over their on-demand availability.

Model Brooks Nader has revealed her regret over undergoing liposuction, stating she 'forever' regrets it due to unwanted dimples and ripples. She also discussed other cosmetic procedures like fillers and the use of weight-loss drugs to advance her career.

Pharmaceutical company Novo Nordisk is planning to broaden the availability of its weight-loss medications within the Japanese market.

If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.

Restaurant stocks are facing difficulties at the start of 2026, grappling with inflation, inconsistent economic growth, and the widespread use of weight-loss drugs, prompting a search for buying opportunities.

Eli Lilly issued an urgent public warning over compounded weight-loss drugs containing vitamin B12

Companies producing sauces and spices are seeing increased deal interest, as the rise of GLP-1 weight-loss drugs is reportedly leading Americans to seek out more flavorful, 'hot stuff'.

Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers  WSJ

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.

New research, based on animal model trials in the UK, suggests that GLP-1 weight-loss drugs could prevent 'no-reflow' complications in heart attack recovery, potentially saving lives.

New research indicates that GLP-1 weight-loss drugs can affect sexual function, with a significant percentage of users reporting changes in their sex lives.

Leading global food and beverage manufacturers, including PepsiCo and Coca-Cola, are set to transform their product portfolios by 2026, focusing on simplifying ingredients in response to the impact of weight-loss medications.

Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%. This move aims to make the medications more affordable for patients.

Novo's stumbles burnish Lilly's widening lead in weight-loss drugs  Reuters

Restaurant owners, chefs, and food staff discuss their experiences with weight-loss drugs, noting changes in appetite and eating habits while working around food.

McDonald's is reportedly testing a new high-protein menu in response to the growing number of consumers using GLP-1 weight-loss drugs and seeking healthier options.

Australian researchers are cautioning that popular GLP-1 weight-loss drugs may lead to scurvy, a historic 'pirate disease,' due to potential poor nutrition and vitamin C deficiency.

The article discusses various treatments for 'Ozempic face,' a cosmetic side effect associated with weight-loss drugs, suggesting options beyond surgical intervention. Surgeons recommend waiting several months before opting for a permanent solution.

Research suggests that an individual's genetic predisposition can play a role in how effectively weight-loss medications such as Wegovy and Mounjaro work, with some people losing less weight even with medication.

An AIIMS endocrinologist discusses whether generic weight-loss drugs should be classified under Schedule H, requiring a doctor's prescription for sale in India.

Novo and Lilly launched their obesity drugs in India last year. The market is forecast to reach ₹80 billion ($851.79 million) by 2030.

Potato farmers are facing a massive surplus as the widespread use of weight-loss medications reduces food demand, putting millions of pounds of potatoes at risk of spoiling.

New weight-loss drugs are being hailed as a medical revolution, but the article highlights that society’s struggle with body size and beauty is a centuries-old issue.

Scientists are scrutinizing weight-loss drugs like Wegovy, which have revolutionized medicine, to investigate a rare but potential risk of eye damage, as their growing popularity raises new safety questions.

India is poised to enter the semaglutide market with affordable weight-loss drugs, with analysts predicting a potential billion-dollar market if priced and implemented correctly.

The government (presumably India) is increasing its scrutiny of GLP-1 weight-loss drugs amidst growing concerns over their unauthorized sales and distribution.

Prices for weight-loss drugs are decreasing in the US market, prompting questions about whether this trend can be replicated elsewhere.

India could soon get a lot thinner - at least in theory.

When Miracle Weight-Loss Drugs Lose Their Edge  WSJ

The weight loss jabs Ozempic, Mounjaro and Weg­ovy — a type of medicine containing semaglutide — are increasingly being seen as a medical wonder of the age.

Lindt reports that users of weight-loss drugs are consuming more chocolate, not less, challenging common assumptions about dietary changes.

A preliminary study suggests that GLP-1 drugs, typically used for diabetes and weight loss, could significantly reduce the need for migraine medication in individuals suffering from chronic migraines.

Jon Taffer says GLP-1 weight-loss medications are hurting restaurants by reducing how much customers eat and drink, making the industry challenging.

The article discusses whether popular weight-loss drugs like Ozempic and Mounjaro are covered by insurance in the UAE, a growing concern for patients.

Brazilian influencer Larissa da Silva Caetano Anunciacao, known as Larissa Caetano, and her husband were arrested on February 24th on suspicion of illegally selling weight-loss medications via Instagram.

Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%.

This article explains the mechanisms of action for popular weight-loss drugs like Mounjaro and Wegovy, detailing how they work and their current availability to patients through the NHS and private markets.

A mother expresses concern over her son's financial ruin after his girlfriend spent over $1,000 a month on weight-loss drugs, sparking a debate about responsibility.

Eli Lilly has delivered positive news for investors, with implications that reach beyond its well-known weight-loss drug portfolio.